Drugs that contain Teriparatide
1. Forteo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7144861 | LILLY | Stabilized teriparatide solutions |
Dec, 2018
(5 years ago) | |
| US7550434 | LILLY | Stabilized teriparatide solutions |
Dec, 2018
(5 years ago) | |
| US6770623 | LILLY | Stabilized teriparatide solutions |
Dec, 2018
(5 years ago) | |
| US6977077 | LILLY | Method of increasing bone toughness and stiffness and reducing fractures |
Aug, 2019
(4 years ago) | |
| US7163684 | LILLY | Method of increasing bone toughness and stiffness and reducing fractures |
Aug, 2019
(4 years ago) | |
| US7351414 | LILLY | Method of reducing the risk of bone fracture |
Aug, 2019
(4 years ago) | |
| US7517334 | LILLY | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
Mar, 2025
(11 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-302) | Nov 16, 2023 |
| New Indication(I-602) | Jul 22, 2012 |
Market Authorisation Date: 25 June, 2008
Treatment: A method of treating osteoporosis; Forteo is indicated for the treatment of post menopausal women with osteoporosis who are at high risk for fracture; Method of treating osteoporosis in a post-menopau...
Dosage: SOLUTION;SUBCUTANEOUS
How can I launch a generic of FORTEO before it's drug patent expiration?
More Information on Dosage
FORTEO family patents
